A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants.

Tilahun Yilma, S. S. Ristow, B. Moss, L. Jones

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We describe a novel approach of producing monoclonal antibodies (MABs) to one specific protein of a virus or other agent consisting of several proteins, without the use of purified antigen in either the immunization or screening phase of the procedure. This method has general application in the production of MABs when the antigen cannot be obtained in a pure form, but the gene is available. We illustrate this application by producing MAB specific to the nucleocapsid protein (N) of vesicular stomatitis virus serotype Indiana (VSV-IN) from BALB/c mice immunized with an infectious vaccinia virus recombinant vector (v38) that expresses the N gene of VSV-IN. This novel method of immunization obviates the need for initial purification of the protein antigen and injection of adjuvants with the isolated protein as is done in traditional MAB production.

Original languageEnglish (US)
Pages (from-to)329-335
Number of pages7
JournalHybridoma
Volume6
Issue number4
StatePublished - Aug 1987
Externally publishedYes

Fingerprint

Vaccinia virus
Vesicular stomatitis Indiana virus
Monoclonal Antibodies
Antigens
Immunization
Proteins
Nucleocapsid Proteins
Genes
Antibody Formation
Viruses
Injections
Serogroup

ASJC Scopus subject areas

  • Genetics
  • Immunology

Cite this

A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. / Yilma, Tilahun; Ristow, S. S.; Moss, B.; Jones, L.

In: Hybridoma, Vol. 6, No. 4, 08.1987, p. 329-335.

Research output: Contribution to journalArticle

Yilma, T, Ristow, SS, Moss, B & Jones, L 1987, 'A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants.', Hybridoma, vol. 6, no. 4, pp. 329-335.
Yilma, Tilahun ; Ristow, S. S. ; Moss, B. ; Jones, L. / A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. In: Hybridoma. 1987 ; Vol. 6, No. 4. pp. 329-335.
@article{9637dd93817440b696ef891224a3c26a,
title = "A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants.",
abstract = "We describe a novel approach of producing monoclonal antibodies (MABs) to one specific protein of a virus or other agent consisting of several proteins, without the use of purified antigen in either the immunization or screening phase of the procedure. This method has general application in the production of MABs when the antigen cannot be obtained in a pure form, but the gene is available. We illustrate this application by producing MAB specific to the nucleocapsid protein (N) of vesicular stomatitis virus serotype Indiana (VSV-IN) from BALB/c mice immunized with an infectious vaccinia virus recombinant vector (v38) that expresses the N gene of VSV-IN. This novel method of immunization obviates the need for initial purification of the protein antigen and injection of adjuvants with the isolated protein as is done in traditional MAB production.",
author = "Tilahun Yilma and Ristow, {S. S.} and B. Moss and L. Jones",
year = "1987",
month = "8",
language = "English (US)",
volume = "6",
pages = "329--335",
journal = "Monoclonal Antibodies in Immunodiagnosis and Immunotherapy",
issn = "2167-9436",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants.

AU - Yilma, Tilahun

AU - Ristow, S. S.

AU - Moss, B.

AU - Jones, L.

PY - 1987/8

Y1 - 1987/8

N2 - We describe a novel approach of producing monoclonal antibodies (MABs) to one specific protein of a virus or other agent consisting of several proteins, without the use of purified antigen in either the immunization or screening phase of the procedure. This method has general application in the production of MABs when the antigen cannot be obtained in a pure form, but the gene is available. We illustrate this application by producing MAB specific to the nucleocapsid protein (N) of vesicular stomatitis virus serotype Indiana (VSV-IN) from BALB/c mice immunized with an infectious vaccinia virus recombinant vector (v38) that expresses the N gene of VSV-IN. This novel method of immunization obviates the need for initial purification of the protein antigen and injection of adjuvants with the isolated protein as is done in traditional MAB production.

AB - We describe a novel approach of producing monoclonal antibodies (MABs) to one specific protein of a virus or other agent consisting of several proteins, without the use of purified antigen in either the immunization or screening phase of the procedure. This method has general application in the production of MABs when the antigen cannot be obtained in a pure form, but the gene is available. We illustrate this application by producing MAB specific to the nucleocapsid protein (N) of vesicular stomatitis virus serotype Indiana (VSV-IN) from BALB/c mice immunized with an infectious vaccinia virus recombinant vector (v38) that expresses the N gene of VSV-IN. This novel method of immunization obviates the need for initial purification of the protein antigen and injection of adjuvants with the isolated protein as is done in traditional MAB production.

UR - http://www.scopus.com/inward/record.url?scp=0023391067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023391067&partnerID=8YFLogxK

M3 - Article

C2 - 3040579

AN - SCOPUS:0023391067

VL - 6

SP - 329

EP - 335

JO - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

JF - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

SN - 2167-9436

IS - 4

ER -